The outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved
slowly over the past 25 years. This improvement may be due to early aneurysm repair by …

Outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved over
the last decades. Yet, case fatality remains nearly 40% and survivors often have permanent …

Introduction In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial
variability exists in the use and timing of outcomes and endpoints, which complicates …

Background and Purpose—Methods of performing and reporting randomized clinical trials
(RCTs) are available, but weaknesses still occur. For observational studies, methodology is …

Researchers and other stakeholders continue to express concern about the failure of
randomized clinical trials (RCT) in subarachnoid hemorrhage (SAH) to show efficacy of new …

Subarachnoid hemorrhage (SAH) is a common and fre-quently devastating condition,
accounting for 5% of all strokes and affecting as many as 30 000 Americans each year. 1, 2 …

There has been limited new high-level evidence generated to guide aneurysmal
subarachnoid hemorrhage (aSAH) management in the past decade. The choice of outcome …

Aneurysmal subarachnoid hemorrhage (SAH) affects six to nine people per 100,000 per
year, has a 35% mortality, and leaves many with lasting disabilities, often related to cognitive …

Aneurysmal subarachnoid hemorrhage (SAH) accounts for about 5% of all strokes and
continues to be a major cause of morbidity and mortality, especially in younger patients …

OBJECTIVE Differences in clinical outcomes between centers and countries may reflect
variation in patient characteristics, diagnostic and therapeutic policies, or quality of care. The …